Tolcapone

Tolcapone is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.

Tolcapone is a selective, reversible catechol-O-methyltransferase (COMT) inhibitor used as adjunctive therapy to levodopa/carbidopa in Parkinson's disease. It prolongs levodopa action by inhibiting peripheral and central dopamine metabolism.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Parkinson's disease adjunctive therapy
• COMT inhibition
• Levodopa plasma half-life extension
• End-of-dose fluctuation control

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings